Featured Studies

Doctors at the National Institutes of Health (NIH) are enrolling people with LAM into a research study. LAM is a rare progressive lung disease that usually strikes women during their childbearing years, between the onset of puberty and menopause. One possible treatment to improve breathing in patients with LAM is inhaled albuterol. Albuterol can be given using a hand held inhaler or with a nebulizer. The study wants to compare these methods to see which method improves lung function in patients with LAM.

The National Institute of Dental and Craniofacial Research at the NIH Clinical Center is looking for volunteers who need to have their wisdom teeth removed. Researchers will evaluate people who need to have their wisdom teeth removed. The removed wisdom teeth will be studied and used for further research.

Researchers at the National Institutes of Health (NIH) Clinical Center seek healthy women to participate in a research study. Doctors want to learn how the body burns energy at different temperatures. Compensation is provided.

Researchers at the National Institutes of Health Clinical Center seek adults with or without gum disease (periodontal disease) to join a research study. Doctors want to learn how a person's immune system affects the health of the mouth. Compensation will be offered.

Researchers at the National Institutes of Health (NIH) Clinical Center are testing if spironolactone can be used to treat PAH. Spironolactone is a medication that can help with fluid retention, however it may also be beneficial to adults with PAH by controlling inflammation and improving blood vessel function in the lungs.

The National Institute of Neurological Disorders and Stroke at the National Institutes of Health Clinical Center is looking for individuals with severe epilepsy or individuals who have experienced persistent seizure activity that cannot be controlled with medication, to participate in this research study. The goal of this research study is to provide surgical treatment to control these types of seizures. Participation requires an inpatient stay of up to 4 weeks, plus 3 outpatient visits within 2 years after surgery.

Thyroid cancer accounts for the vast majority of all types of cancer and little is known about the possible genes that may cause the cancer. An estimated 5% of all thyroid cancers are hereditary. If three or more first-degree relatives are affected, there is a greater than 94% chance that these cases are familial non-medullary thyroid cancer (FNMTC). Researchers at the National Institutes of Health (NIH) are conducting a research study to develop the best ways to evaluate, determine best screening strategy, and identify genes that may indicate vulnerability to FNMTC.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is conducting a pilot intervention study for patients diagnosed with idiopathic membranous nephropathy. The purpose of this study is to evaluate the safety and effectiveness of Rituximab plus Cyclosporine in the treatment of membranous nephropathy. There is no cost for study-related medications or tests received.